E-viri
PDF
Recenzirano
Odprti dostop
-
Sentilhes, Loïc; Sénat, Marie V; Le Lous, Maëla; Winer, Norbert; Rozenberg, Patrick; Kayem, Gilles; Verspyck, Eric; Fuchs, Florent; Azria, Elie; Gallot, Denis; Korb, Diane; Desbrière, Raoul; Le Ray, Camille; Chauleur, Céline; de Marcillac, Fanny; Perrotin, Franck; Parant, Olivier; Salomon, Laurent J; Gauchotte, Emilie; Bretelle, Florence; Sananès, Nicolas; Bohec, Caroline; Mottet, Nicolas; Legendre, Guillaume; Letouzey, Vincent; Haddad, Bassam; Vardon, Delphine; Madar, Hugo; Mattuizzi, Aurélien; Daniel, Valérie; Regueme, Sophie; Roussillon, Caroline; Benard, Antoine; Georget, Aurore; Darsonval, Astrid; Deneux-Tharaux, Catherine
New England journal of medicine/The New England journal of medicine, 04/2021, Letnik: 384, Številka: 17Journal Article
In this trial involving women undergoing cesarean delivery (all of whom received prophylactic uterotonic medication), tranexamic acid treatment resulted in a significantly lower incidence of estimated blood loss greater than 1000 ml or red-cell transfusion by day 2 than placebo, but it did not reduce the risk of hemorrhage-related secondary clinical outcomes.
